Global Animal Vaccines Market Size, Trends, and Growth Opportunity, By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Companion), By Route of Administration (Subcutaneous, Intramuscular, Intranasal), By Distribution Channel (Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, Others), By Region and forecast till 2027.
Global Animal Vaccines Market
The global Animal Vaccines market size was valued at USD 11.7 billion in 2021 and is expected to expand USD 24.2 billion at a CAGR of 12.25 % during the forecast period 2022- 2027.
Animals are an important source of food, meat, milk, protein and other products like leather and wool .Animal vaccines control the transmission of diseases by protecting animal and human health, which is essential as the public is dependent on animals. Vaccines prevent the transmission of infectious diseases by mimicking the naturally acquired immunity in animals.
Market Drivers
The increasing zoonotic disease, growing livestock population, and rising animal husbandry coupled with the commercialization of animal products act as major factors for growing the animal vaccines market.
The technological advancement in the animal vaccine, the efficient launch of immunization products, and growing awareness among people regarding animal healthcare propelled the growth of the market.
Market Restraints
Lack of animal immunization adoption in farmers due to lack of awareness about their benefits hinders the growth of the global animal vaccines market.
The high cost associated with inoculation Products anticipated the growth of the market. Additionally, less supply of products due to lack of availability restrains the market growth.
COVID-19 Impact on Animal Vaccines Market
An outbreak of covid-19 impacted the market as the lockdown and strict regulations imposed by the government caused a shutdown of manufacturing and disruption in the supply chain. But the growing cases of covid-19 infections in domestic and wild animals increase the acceptance of animal vaccines for safeguarding preventive animal health and government support has driven the market during a pandemic.
Impact of Russia Ukraine War on the Market
The conflict between Russia and Ukraine can have both direct and indirect impacts on the animal vaccines market:
Disruptions in the supply chain: Many Animal Vaccines manufacturers source components from Russia and Ukraine. The war may cause supply chain disruptions and delays, affecting animal vaccine production and delivery.
Economic sanctions: Economic sanctions imposed on Russia may have an impact on the overall economy, as well as the demand for animal vaccines in the region.
Market Segmentation
The global Animal Vaccines Market is segmented on the basis of Product, Animal Type, Route Of Administration, Distribution Channel And Region. On the basis of Product, it is segmented into Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, and Recombinant Vaccines. On the basis of Animal Type, it is segmented into Livestock, Companion. On the basis of the Route of Administration, it is segmented into Subcutaneous, Intramuscular, and Intranasal. On the basis of the Distribution Channel, it is segmented into Veterinary Hospitals, Veterinary Clinics, Pharmacies & Drug Stores, and Others. On the basis of Region, it is segmented into North America, Europe, Asia Pacific, Latin America, and MEA.
Regional Analysis
The global Animal Vaccines Market is segmented into five regions North America, Europe, Asia Pacific, Latin America, and MEA. North America dominates the market due to the increasing prevalence of livestock and zoonotic diseases and the rising pet population in this region. Asia Pacific has also witnessed a significant rise in the Animal Vaccines market during the forecast period 2022-2027.
Key Players
Various key players are listed in this report such as Merck & Co Inc, Zoetis, Boehringer Ingelheim International GmbH, Virbac, Biogénesis Bagó, Indian Immunologicals Ltd, Phibro Animal Health Corporation, Neogen Corporation, Intas Pharmaceuticals Ltd, Ourofino Saúde Animal.
Market Taxonomy
By Product
• Attenuated Live Vaccines
• Inactivated Vaccines
• Subunit Vaccines
• DNA Vaccines
• Recombinant Vaccines
By Animal Type
• Livestock
• Companion
By Route of Administration
• Subcutaneous
• Intramuscular
• Intranasal
By Distribution Channel
• Veterinary Hospitals
• Veterinary Clinics
• Pharmacies & Drug Stores
• Others
By Region
• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa
Key Question Addressed by the Report
• What are the Key Opportunities in Global Animal Vaccines Market?
• What will be the growth rate from 2022 to 2027?
• Which segment/region will have the highest growth?
• What are the factors that will impact/drive the Market?
• What is the role of key players in the value chain?
Global Animal Vaccines Market
1 Introduction
1.1 Objective of the Study
1.2 Market definition
1.3 Market Scope
2 Research Methodology
2.1 Data Mining
2.2 Validation
2.3 Primary Interviews
2.4 List of Data Sources
3 Executive Summary
4 Animal Vaccines Market Outlook
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.2.4 Cumulative Impact due to recent Energy Crisis
4.2.5 Cumulative Impact due to nearing economic downturn
4.2.6 Post covid-19 world Supply& Demand conditions
4.2.7 Cumulative Impact of Russia-Ukraine Conflict
4.3 Porters Five Force Model
4.4 Value Chain Analysis
5 Animal Vaccines Market, By Product
5.1 Y-o-Y Growth Comparison, By Product
5.2 Animal Vaccines Market Share Analysis, By Product
5.3 Animal Vaccines Market Size and Forecast, By Product
5.3.1 Attenuated Live Vaccines
5.3.2 Inactivated Vaccines
5.3.3 Subunit Vaccines
5.3.4 DNA Vaccines
5.3.5 Recombinant Vaccines
6 Animal Vaccines Market, By Animal Type
6.1 Y-o-Y Growth Comparison, By Animal Type
6.2 Animal Vaccines Market Share Analysis, By Animal Type
6.3 Animal Vaccines Market Size and Forecast, By Animal Type
6.3.1 Livestock
6.3.2 Companion
7 Animal Vaccines Market, By Route of Administration
7.1 Y-o-Y Growth Comparison, By Route of Administration
7.2 Animal Vaccines Market Share Analysis, By Route of Administration
7.3 Animal Vaccines Market Size and Forecast, By Route of Administration
7.3.1 Subcutaneous
7.3.2 Intramuscular
7.3.3 Intranasal
8 Animal Vaccines Market, By Distribution Channel
8.1 Y-o-Y Growth Comparison, By Distribution Channel
8.2 Animal Vaccines Market Share Analysis, By Distribution Channel
8.3 Animal Vaccines Market Size and Forecast, By Distribution Channel
8.3.1 Veterinary Hospitals
8.3.2 Veterinary Clinics
8.3.3 Pharmacies & Drug Stores
8.3.4 Others
9 Animal Vaccines Market, By Region
9.1 Animal Vaccines Market Share Analysis, By Region
9.2 Animal Vaccines Market Share Analysis, By Region
9.3 Animal Vaccines Market Size and Forecast, By Region
10 North America Animal Vaccines Market Analysis and Forecast (2022 – 2027)
10.1 Introduction
10.2 North America Animal Vaccines Market Share Analysis, By Product
10.3 North America Animal Vaccines Market Size and Forecast, By Animal Type
10.4 North America Animal Vaccines Market Size and Forecast, By Route of Administration
10.5 North America Animal Vaccines Market Size and Forecast, By Distribution Channel
10.6 North America Animal Vaccines Market Size and Forecast, By Country
10.6.1 U.S.
10.6.2 Canada
10.6.3 Mexico
11 Europe Animal Vaccines Market Analysis and Forecast (2022 – 2027)
11.1 Introduction
11.2 Europe Animal Vaccines Market Share Analysis, By Product
11.3 Europe Animal Vaccines Market Size and Forecast, By Animal Type
11.4 Europe Animal Vaccines Market Size and Forecast, By Route of Administration
11.5 Europe Animal Vaccines Market Size and Forecast, By Distribution Channel
11.6 Europe Animal Vaccines Market Size and Forecast, By Country
11.6.1 Germany
11.6.2 France
11.6.3 UK
11.6.4. Rest of Europe
12 Asia Pacific Animal Vaccines Market Analysis and Forecast (2022 – 2027)
12.1 Introduction
12.2 Asia Pacific Animal Vaccines Market Share Analysis, By Product
12.3 Asia Pacific Animal Vaccines Market Size and Forecast, By Animal Type
12.4 Asia Pacific Animal Vaccines Market Size and Forecast, By Route of Administration
12.5 Asia Pacific Animal Vaccines Market Size and Forecast, By Distribution Channel
12.6 Asia Pacific Animal Vaccines Market Size and Forecast, By Country
12.6.1 China
12.6.2 Japan
12.6.3 India
12.6.4. Rest of Asia Pacific
13 Latin America Animal Vaccines Market Analysis and Forecast (2022 – 2027)
13.1 Introduction
13.2 Latin America Animal Vaccines Market Share Analysis, By Product
13.3 Latin America Animal Vaccines Market Size and Forecast, By Animal Type
13.4 Latin America Animal Vaccines Market Size and Forecast, By Route of Administration
13.5 Latin America Animal Vaccines Market Size and Forecast, By Distribution Channel
13.6 Latin America Animal Vaccines Market Size and Forecast, Country
13.6.1. Brazil
13.6.2. Rest of Latin America
14 Middle East Animal Vaccines Market Analysis and Forecast (2022 – 2027)
14.1 Introduction
14.2 Middle East Animal Vaccines Market Share Analysis, By Product
14.3 Middle East Animal Vaccines Market Size and Forecast, By Animal Type
14.4 Middle East Animal Vaccines Market Size and Forecast, By Route of Administration
14.5 Middle East Animal Vaccines Market Size and Forecast, By Distribution Channel
14.6 Middle East Animal Vaccines Market Size and Forecast, By Country
14.6.1. Saudi Arabia
14.6.2. UAE
14.6.3. Egypt
14.6.4. Kuwait
14.6.5. South Africa
15 Competitive Analysis
15.1 Competition Dashboard
15.2 Market share Analysis of Top Vendors
15.3 Key Development Strategies
16 Company Profiles
16.1 Merck & Co Inc
16.1.1 Overview
16.1.2 Offerings
16.1.3 Key Financials
16.1.4 Business Segment & Geographic Overview
16.1.5 Key Market Developments
16.1.6 Key Strategies
16.2 Zoetis
16.2.1 Overview
16.2.2 Offerings
16.2.3 Key Financials
16.2.4 Business Segment & Geographic Overview
16.2.5 Key Market Developments
16.2.6 Key Strategies
16.3 Boehringer Ingelheim International GmbH
16.3.1 Overview
16.3.2 Offerings
16.3.3 Key Financials
16.3.4 Business Segment & Geographic Overview
16.3.5 Key Market Developments
16.3.6 Key Strategies
16.4 Virbac
16.4.1 Overview
16.4.2 Offerings
16.4.3 Key Financials
16.4.4 Business Segment & Geographic Overview
16.4.5 Key Market Developments
16.4.6 Key Strategies
16.5 Biogénesis Bagó
16.5.1 Overview
16.5.2 Offerings
16.5.3 Key Financials
16.5.4 Business Segment & Geographic Overview
16.5.5 Key Market Developments
16.5.6 Key Strategies
16.6 Indian Immunologicals Ltd
16.6.1 Overview
16.6.2 Offerings
16.6.3 Key Financials
16.6.4 Business Segment & Geographic Overview
16.6.5 Key Market Developments
16.6.6 Key Strategies
16.7. Phibro Animal Health Corporation
16.7.1 Overview
16.7.2 Offerings
16.7.3 Key Financials
16.7.4 Business Segment & Geographic Overview
16.7.5 Key Market Developments
16.7.6 Key Strategies
16.8 Neogen Corporation
16.8.1 Overview
16.8.2 Offerings
16.8.3 Key Financials
16.8.4 Business Segment & Geographic Overview
16.8.5 Key Market Developments
16.8.6 Key Strategies
16.9 Intas Pharmaceuticals Ltd
16.9.1 Overview
16.9.2 Offerings
16.9.3 Key Financials
16.9.4 Business Segment & Geographic Overview
16.9.5 Key Market Developments
16.9.6 Key Strategies
16.10 Ourofino Saúde Animal
16.10.1 Overview
16.10.2 Offerings
16.10.3 Key Financials
16.10.4 Business Segment & Geographic Overview
16.10.5 Key Market Developments
16.10.6 Key Strategies
